Get started
Author

Fernando Salvador

Observed names: F. Salvador, Salvador F., Salvador, Fernando
Observed institutions: Universitat Autònoma de Barcelona, Universitat de València, Instituto de Salud Carlos III, Hospital Universitari Arnau de Vilanova, Hospital Universitari i Politècnic La Fe, Hospital Universitario Fundación Alcorcón, Vall d'Hebron Institut de Recerca, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Instituto Ramón y Cajal de Investigación Sanitaria, Vall d'Hebron Hospital Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Solti, Comunidad de Madrid, Institut Català de la Salut, Hospital Universitario Ramón y Cajal, Instituto de Investigación Sanitaria La Fe, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Red de Investigación Cooperativa en Enfermedades Tropicales, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, Universitat de Barcelona
ORCID: 0000-0002-0546-1354
Observed ORCID: 0000-0002-0546-1354
OpenAlex ID: A5058837514
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
2014 · Israel Molina, Jordi Gómez i Prat, et al. · New England Journal of Medicine · 604
PDF
Experimental and Clinical Treatment of Chagas Disease: A Review
2017 · Policarpo Ademar Sales Junior, Israel Molina, et al. · American Journal of Tropical Medicine and Hygiene · 305
PDF
Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers
2015 · I. Molina, F. Salvador, et al. · Antimicrobial Agents and Chemotherapy · 107
PDF
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
2021 · Belén Gutiérrez-Gutiérrez, María Dolores del Toro, et al. · The Lancet Infectious Diseases · 95
PDF
Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile
2013 · F. Salvador, B. Trevióo, et al. · Clinical Microbiology and Infection · 75
Prevalence and molecular characterization of Strongyloides stercoralis, Giardia duodenalis, Cryptosporidium spp., and Blastocystis spp. isolates in school children in Cubal, Western Angola
2018 · Elena Dacal, José M. Saugar, et al. · Parasites & Vectors · 65
PDF
Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II superiority clinical trial
2020 · D. Molina-Morant, M. L. Fernández, et al. · Trials · 62
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Usefulness of Strongyloides stercoralis Serology in the Management of Patients with Eosinophilia
2014 · Fernando Salvador, Elena Sulleiro, et al. · American Journal of Tropical Medicine and Hygiene · 59
The use of posaconazole against Chagas disease
2015 · Israel Molina, Fernando Salvador, et al. · Current Opinion in Infectious Diseases · 56
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression
2019 · Pau Bosch-Nicolau, Maria Ubals, et al. · PLoS neglected tropical diseases · 55
PDF
Tropical Diseases Screening in Immigrant Patients with Human Immunodeficiency Virus Infection in Spain
2013 · Fernando Salvador, Israel Molina, et al. · American Journal of Tropical Medicine and Hygiene · 54
Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials
2017 · I. Molina, F. Salvador, et al. · Antimicrobial Agents and Chemotherapy · 50
Strongyloides stercoralis infection: A systematic review of endemic cases in Spain
2019 · Maria Barroso, Fernando Salvador, et al. · PLoS neglected tropical diseases · 49
PDF
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial
2024 · Pau Bosch-Nicolau, Marisa L Fernández, et al. · The Lancet Infectious Diseases · 48
PDF
Red blood cell transfusion‐transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report
2016 · Mar Riveiro‐Barciela, Silvia Sauleda, et al. · Transfusion · 48
Immunosuppression and Chagas disease; experience from a non-endemic country
2015 · F. Salvador, A. Sánchez-Montalvá, et al. · Clinical Microbiology and Infection · 48
Actualización en enfermedad de Chagas
2016 · Israel Molina, Fernando Salvador, et al. · Enfermedades Infecciosas y Microbiología Clínica · 47
Persistence of Zika Virus in Body Fluids — Final Report
2019 · Adrián Sánchez-Montalvá, Fernando Salvador, et al. · New England Journal of Medicine · 45
PDF
Evaluation of Cytokine Profile and HLA Association in Benznidazole Related Cutaneous Reactions in Patients With Chagas Disease
2015 · Fernando Salvador, Adrián Sánchez-Montalvá, et al. · Clinical Infectious Diseases · 45
Ultrasensitive Real-Time PCR for the Clinical Management of Visceral Leishmaniasis in HIV-Infected Patients
2013 · Israel Molina, Roser Fisa, et al. · American Journal of Tropical Medicine and Hygiene · 45
PDF
Serodiscordance in chronic Chagas disease diagnosis: a real problem in non-endemic countries
2016 · Z. Moure, A. Angheben, et al. · Clinical Microbiology and Infection · 43
PDF
Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country
2015 · Fernando Salvador, Ibai Los-Arcos, et al. · Medicine · 43
Approach to amoebic colitis: Epidemiological, clinical and diagnostic considerations in a non-endemic context (Barcelona, 2007-2017)
2019 · Sílvia Roure, Lluís Valerio, et al. · PLoS ONE · 42
PDF
Imported malaria in Spain (2009–2016): results from the +REDIVI Collaborative Network
2017 · for the +REDIVI Study Group, Francesca F. Norman, et al. · Malaria Journal · 39
PDF
Works count: 209
Citation count: 3,915
H-index: 34
I10-index: 90
Year
Topic
Type